The GPX3 gene was shown to display epigenetic inactivation in prostate cancer, ovarian clear cell adenocarcinoma, gastric carcinoma and Barret's disease [11-16]. The gene discussed is GPX3; the disease is ovarian clear cell adenocarcinoma.